Larvol Delta - Aulos-Bioscience-Presents-Phase-2-Dose-Selection-Data-for-Novel-IL2-Therapeutic-Antibody-AU007-at-36th-EORTCNCIAACR-Symposium-on-Molecular-Targets-and-Cancer-Therapeutics

AU-007 - Aulos Biosci

https://www.businesswire.com/news/home/20241023279405/en/Aulos-Bioscience-Presents-Phase-2-Dose-Selection-Data-for-Novel-IL-2-Therapeutic-Antibody-AU-007-at-36th-EORTC-NCI-AACR-Symposium-on-Molecular-Targets-and-Cancer-Therapeutics

Oct 23, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next